IFNA2 and colorectal carcinoma: Similarly, IFN-α combined with epigenetic modulators (azacitidine and romidepsin) strongly inhibits invasive signaling pathways in both metastatic cells and cancer stem cells of CRC, which improves DCs phagocytosis of cancer cells by triggering cell death with immunogenic features 196.